Your browser doesn't support javascript.
loading
A multicenter, open-label, efficacy, pharmacokinetic, and safety study of adalimumab in Japanese patients with ankylosing spondylitis.
Kobayashi, Shigeto; Harigai, Masayoshi; Mozaffarian, Neelufar; Pangan, Aileen L; Sharma, Shringi; Brown, L Steven; Miyasaka, Nobuyuki.
Affiliation
  • Kobayashi S; Department of Internal Medicine, Rheumatology, Juntendo Koshigaya Hospital, Juntendo University School of Medicine, 560 Fukuroyama, Koshigaya, Saitama, 343-0032, Japan. shigeto@juntendo.ac.jp
Mod Rheumatol ; 22(4): 589-97, 2012 Aug.
Article in En | MEDLINE | ID: mdl-22205117
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Spondylitis, Ankylosing / Antirheumatic Agents / Antibodies, Monoclonal, Humanized Type of study: Clinical_trials Aspects: Patient_preference Limits: Adult / Female / Humans / Male Country/Region as subject: Asia Language: En Journal: Mod Rheumatol Year: 2012 Document type: Article Affiliation country: Japón Country of publication: Reino Unido
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Spondylitis, Ankylosing / Antirheumatic Agents / Antibodies, Monoclonal, Humanized Type of study: Clinical_trials Aspects: Patient_preference Limits: Adult / Female / Humans / Male Country/Region as subject: Asia Language: En Journal: Mod Rheumatol Year: 2012 Document type: Article Affiliation country: Japón Country of publication: Reino Unido